• Nystatin (Fungicidin): Advanced Antifungal Workflows & Syner

  2026-06-21

  Nystatin (Fungicidin) from APExBIO sets the benchmark for antifungal research, delivering reproducible results against Candida and Aspergillus models. Explore how cutting-edge synergy with moxidectin and optimized protocols can elevate your mycology workflows while overcoming resistance and solubility challenges.

• Salvianolic Acid B Inhibits LH2 to Reduce Pulmonary Fibrosis

  2026-06-20

  This study demonstrates that Salvianolic acid B attenuates pulmonary fibrosis by suppressing lysyl hydroxylase 2 (LH2) expression, thereby reducing abnormal collagen cross-linking and extracellular matrix stiffening. The findings provide a mechanistically grounded approach for targeting fibrotic remodeling with natural compounds, offering new directions for translational research in fibrotic lung diseases.

• Ceramide-Mediated Autophagy Drives RGNNV Replication in Fish

  2026-06-19

  This study uses lipidomics to reveal that ceramide accumulation, driven by red-spotted grouper nervous necrosis virus (RGNNV) infection and its capsid protein, facilitates viral replication by promoting autophagy in fish cells. Disruption of ceramide synthesis suppresses infection, highlighting ceramide metabolism as a critical target for interventions in viral nervous necrosis.

• AMPK–SQSTM1 Feedback Enhances Antioxidant Defense in Metabol

  2026-06-19

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 during metabolic stress, leading to synergistic activation of AMPK and NFE2L2/NRF2 and improved antioxidant defenses. These findings provide new mechanistic insights into tumor adaptation under stress and offer strategic directions for future research in cancer metabolism.

• HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells

  2026-06-18

  This study elucidates how Epstein-Barr virus (EBV)–induced dedifferentiation in nasopharyngeal carcinoma (NPC) arises from epigenetic repression of CEBPA by LMP1-driven STAT5A-HDAC1/2 recruitment. The research demonstrates that HDAC inhibitors can restore differentiation, revealing a promising epigenetic intervention for poorly differentiated solid tumors.

• Chlamydial Vesicle-Mediated OmpA Delivery Blocks Mitochondri

  2026-06-18

  This study uncovers how Chlamydia trachomatis utilizes vesicles to deliver the beta-barrel protein OmpA to host mitochondria, thereby inhibiting apoptosis. The findings provide novel mechanistic insight into bacterial modulation of host cell death and highlight strategies for dissecting apoptosis using caspase inhibition tools.

• SU6656 Src Tyrosine Kinases Inhibitor: Innovations in Platel

  2026-06-17

  Explore the unique role of SU6656 Src tyrosine kinases inhibitor in accelerating hiPSC-derived platelet production and enhancing radiotherapy efficacy. Delve into breakthrough protocols, mechanistic insights, and practical considerations for advanced cancer and regenerative medicine research.

• Lysosomal β-Galactosidase Staining Kit: Deep Mechanistic Ins

  2026-06-17

  Discover how the Lysosomal β-Galactosidase Staining Kit enables precise, artifact-free detection of lysosomal enzyme activity and informs advanced cellular senescence workflows. This article uniquely explores mechanistic connections to chemoresistance, providing practical assay guidance for oncology research.

• Praeruptorin A: Mechanistic Insights and Translational Lever

  2026-06-16

  Explore the multifaceted potential of Praeruptorin A, an angular pyranocoumarin compound, as a next-generation tool for translational research. This article unpacks its unique mechanisms—ranging from ferroptosis inhibition to anti-inflammatory action—while offering strategic guidance on protocol design and cross-domain application.

• Metabolomics Reveals Resistance Pathways in Carbapenemase-Pr

  2026-06-16

  This study applies LC-MS/MS metabolomics to identify and characterize metabolic signatures that distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE isolates. The findings highlight specific metabolic pathways linked to antimicrobial resistance, offering mechanistic insight and paving the way for rapid, biomarker-driven diagnostics.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-06-15

  This study demonstrates that naturally occurring angiotensin peptide fragments, including N-terminally truncated forms, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor. These mechanistic insights into peptide-mediated modulation of viral entry provide a new angle for understanding COVID-19 pathogenesis and highlight potential targets for therapeutic intervention.

• TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M

  2026-06-15

  The study by Liao et al. identifies TANK-binding kinase 1 (TBK1) as a driver of painful diabetic neuropathy (PDN) through microglial pyroptosis in the spinal dorsal horn. Targeted TBK1 inhibition, either by siRNA or amlexanox, reduced neuropathic pain and neuroinflammation, providing mechanistic insight and supporting TBK1 as a promising therapeutic target for PDN.

• 2X HyperFusion High-Fidelity Master Mix: Precision for Cloni

  2026-06-14

  Unlock ultra-high accuracy and robust performance for cloning, CRISPR, and immunogenomics with the 2X HyperFusion High-Fidelity Master Mix. Its advanced DNA polymerase enables blunt-end generation and error rates 50-fold lower than Taq, streamlining even the most demanding PCR applications.

• Amyloid Beta-Peptide (1-40): Illuminating Microglial Modulat

  2026-06-13

  Explore how Amyloid Beta-Peptide (1-40) (human) advances Alzheimer’s disease research by revealing novel microglial regulatory pathways and supporting innovative assay strategies. This in-depth analysis offers new scientific insights and protocol guidance beyond conventional peptide studies.

• EZ Cap™ Human PTEN mRNA: Redefining Tumor Suppressor Gene Re

  2026-06-12

  Explore how EZ Cap™ Human PTEN mRNA advances tumor suppressor gene mRNA research with superior stability and translation. This article analyzes its unique molecular features, practical applications, and the latest breakthroughs in mRNA-based cancer therapy.

803 records 16/54 page Previous Next First page 上5页 1617181920 下5页 Last page